206 related articles for article (PubMed ID: 19235767)
1. Human natural killer receptors, co-receptors, and their ligands.
Biassoni R
Curr Protoc Immunol; 2009 Feb; Chapter 14():14.10.1-14.10.40. PubMed ID: 19235767
[TBL] [Abstract][Full Text] [Related]
2. Human Natural Killer Receptors, Co-Receptors, and Their Ligands.
Biassoni R; Malnati MS
Curr Protoc Immunol; 2018 Apr; 121(1):e47. PubMed ID: 30040219
[TBL] [Abstract][Full Text] [Related]
3. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses.
Nedvetzki S; Sowinski S; Eagle RA; Harris J; Vély F; Pende D; Trowsdale J; Vivier E; Gordon S; Davis DM
Blood; 2007 May; 109(9):3776-85. PubMed ID: 17218381
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell licensing during viral infection.
Orr MT; Lanier LL
Adv Exp Med Biol; 2011; 780():37-44. PubMed ID: 21842363
[TBL] [Abstract][Full Text] [Related]
6. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
7. Human NK cells: From surface receptors to clinical applications.
Moretta L; Pietra G; Vacca P; Pende D; Moretta F; Bertaina A; Mingari MC; Locatelli F; Moretta A
Immunol Lett; 2016 Oct; 178():15-9. PubMed ID: 27185471
[TBL] [Abstract][Full Text] [Related]
8. Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis.
Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A
Immunol Lett; 2005 Aug; 100(1):7-13. PubMed ID: 16109445
[TBL] [Abstract][Full Text] [Related]
9. Regulation of self-ligands for activating natural killer cell receptors.
Lam RA; Chwee JY; Le Bert N; Sauer M; Pogge von Strandmann E; Gasser S
Ann Med; 2013 Jun; 45(4):384-94. PubMed ID: 23701136
[TBL] [Abstract][Full Text] [Related]
10. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
11. Regulatory NK cells in autoimmune disease.
Tian Z; Gershwin ME; Zhang C
J Autoimmun; 2012 Sep; 39(3):206-15. PubMed ID: 22704425
[TBL] [Abstract][Full Text] [Related]
12. MHC-I molecules selectively inhibit cell-mediated cytotoxicity triggered by ITAM-coupled activating receptors and 2B4.
Corral-San Miguel R; Hernández-Caselles T; Ruiz Alcaraz AJ; Martínez-Esparza M; García-Peñarrubia P
PLoS One; 2014; 9(9):e107054. PubMed ID: 25226085
[TBL] [Abstract][Full Text] [Related]
13. A bird's eye view of NK cell receptor interactions with their MHC class I ligands.
Saunders PM; Vivian JP; O'Connor GM; Sullivan LC; Pymm P; Rossjohn J; Brooks AG
Immunol Rev; 2015 Sep; 267(1):148-66. PubMed ID: 26284476
[TBL] [Abstract][Full Text] [Related]
14. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function.
Tremblay-McLean A; Coenraads S; Kiani Z; Dupuy FP; Bernard NF
BMC Immunol; 2019 Jan; 20(1):8. PubMed ID: 30696399
[TBL] [Abstract][Full Text] [Related]
15. The effect of chemotherapy/radiotherapy on cancerous pattern recognition by NK cells.
Rosental B; Appel MY; Yossef R; Hadad U; Brusilovsky M; Porgador A
Curr Med Chem; 2012; 19(12):1780-91. PubMed ID: 22414084
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targets.
Wahle JA; Paraiso KH; Costello AL; Goll EL; Sentman CL; Kerr WG
J Immunol; 2006 Jun; 176(12):7165-9. PubMed ID: 16751359
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction during activation and inhibition of natural killer cells.
Watzl C; Long EO
Curr Protoc Immunol; 2010 Aug; Chapter 11():Unit 11.9B. PubMed ID: 20814939
[TBL] [Abstract][Full Text] [Related]
18. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.
Lu L; Ikizawa K; Hu D; Werneck MB; Wucherpfennig KW; Cantor H
Immunity; 2007 May; 26(5):593-604. PubMed ID: 17509909
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory Receptor Crosslinking Quantitatively Dampens Calcium Flux Induced by Activating Receptor Triggering in NK Cells.
Ganesan S; Höglund P
Front Immunol; 2018; 9():3173. PubMed ID: 30693005
[TBL] [Abstract][Full Text] [Related]
20. NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies.
Magri G; Muntasell A; Romo N; Sáez-Borderías A; Pende D; Geraghty DE; Hengel H; Angulo A; Moretta A; López-Botet M
Blood; 2011 Jan; 117(3):848-56. PubMed ID: 21030563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
